Kristian Humer - Feb 2, 2022 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
CFO and CBO
Signature
/s/ Lara Meisner, Attorney-in-Fact for Kristian Humer
Stock symbol
VRDN
Transactions as of
Feb 2, 2022
Transactions value $
$0
Form type
4
Date filed
2/3/2022, 05:15 PM
Previous filing
Jan 3, 2022
Next filing
Jun 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +90K $0.00 90K Feb 2, 2022 Common Stock 90K $18.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to Issuer through each vesting date.